- Research works
- 119 ▲ 126% vs 2013–17
- Citations
- 3.3k 27.5 per fractional work
- Top-10% rate
- 17.2% record average 16.5%
- Open access
- 48% world 28%
Not ranked overall: Gubra (Denmark) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.7×. Every wedge is a field page.
Who are the top researchers at Gubra (Denmark)?
Ranked on the composite score, Michael Christensen, Michael Feigh and Henrik H. Hansen lead among researchers whose main affiliation is Gubra (Denmark).
- 1 Michael Christensen Denmark · #864,216 worldwide 61 citations · 20 works
- 2 Michael Feigh Denmark · #1,146,566 worldwide 40 citations · 22 works
- 3 Henrik H. Hansen Denmark · #1,326,060 worldwide 30 citations · 16 works
- 4 Ditte Marie Jensen Denmark · #1,503,271 worldwide 10 citations · 33 works
Which keywords describe research at Gubra (Denmark)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Fibrosis, TGF-ß, Epithelial-Mesenchymal Transition, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Metabolic Syndrome, Inflammation and Clinical Guidelines.
- Metformin
- AMP-Activated Protein Kinase
- Cell Signaling
- NAFLD
- ß-Cell Dysfunction
- Right Heart Assessment
- Hepatocellular Carcinoma
- Cancer Therapy
- Drug Discovery
- Pulmonary Hypertension
- Endothelial Dysfunction
- Cardiovascular Outcomes
- Glycemic Control
- Heart Failure
- Insulin Resistance
- Cardiovascular Disease
- Oxidative Stress
- Metabolic Syndrome
- Idiopathic Pulmonary Fibrosis
- TGF-ß
- Fibrosis
- Epithelial-Mesenchymal Transition
- Interstitial Lung Disease
- Inflammation
- Clinical Guidelines
- Chronic Kidney Disease
- Obesity
- Type 2 Diabetes
- Insulin Therapy
- Glucose Control
- Hypertension
- Global Burden
- Echocardiography
- Hepatic Steatosis
- Pancreatic Islets
- Treatment Guidelines
- Tumor Suppression
- NASH
- Weight Loss
- Alzheimer's Disease
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Fibrosis9▲ 90×4 topics
- TGF-ß8▲ 98×2 topics
- Epithelial-Mesenchymal Transition7▲ 143×2 topics
- Idiopathic Pulmonary Fibrosis7▲ 286×1 topic
- Interstitial Lung Disease7▲ 209×1 topic
- Metabolic Syndrome6▲ 13×9 topics
- Inflammation5▲ 4.8×20 topics
- Oxidative Stress4▲ 4.2×12 topics
- Clinical Guidelines3▲ 22×3 topics
- Cardiovascular Disease3▲ 5.2×9 topics
- Chronic Kidney Disease3▲ 24×4 topics
- Insulin Resistance3▲ 13×6 topics
- Obesity3▲ 7.2×10 topics
- Heart Failure3▲ 12×4 topics
- Type 2 Diabetes3▲ 24×3 topics
- Glycemic Control3▲ 31×2 topics
- Insulin Therapy3▲ 40×2 topics
- Cardiovascular Outcomes2▲ 87×1 topic
- Glucose Control2▲ 87×1 topic
- Endothelial Dysfunction2▲ 18×2 topics
- Hypertension2▲ 14×3 topics
- Pulmonary Hypertension2▲ 30×2 topics
- Global Burden2▲ 7.5×3 topics
- Drug Discovery2▲ 17×3 topics
- Echocardiography2▲ 14×2 topics
- Cancer Therapy2▲ 6.3×4 topics
- Hepatic Steatosis2▲ 23×2 topics
- Hepatocellular Carcinoma2▲ 17×3 topics
- Pancreatic Islets2▲ 87×1 topic
- Right Heart Assessment2▲ 88×1 topic
- Treatment Guidelines2▲ 16×1 topic
- ß-Cell Dysfunction2▲ 87×1 topic
- Tumor Suppression2▲ 48×2 topics
- NAFLD2▲ 26×1 topic
- NASH2▲ 26×1 topic
- Cell Signaling2▲ 19×3 topics
- Weight Loss2▲ 17×3 topics
- AMP-Activated Protein Kinase1▲ 68×1 topic
- Alzheimer's Disease1▲ 9.5×2 topics
- Metformin1▲ 93×1 topic
Which research topics does Gubra (Denmark) publish most on?
By volume in 2022–2025: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Diabetes Treatment and Management, Pulmonary Hypertension Research and Treatments and Pancreatic function and diabetes.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 7 works
- 2 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 2 works
- 3 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 2 works
- 4 Pancreatic function and diabetes Surgery 2 works
- 5 Liver Disease Diagnosis and Treatment Epidemiology 2 works
- 6 Metabolism, Diabetes, and Cancer Molecular Biology 1 works
- 7 Diet and metabolism studies Physiology 1 works
- 8 Genetic and Kidney Cyst Diseases Genetics 1 works
- 9 Hormonal Regulation and Hypertension Endocrinology, Diabetes and Metabolism 1 works
- 10 Neuropeptides and Animal Physiology Cellular and Molecular Neuroscience 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Gubra (Denmark)'s research output changed?
Output in 2018–2022 was 126% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Hørsholm
- DHI
- Chr. Hansen (Denmark)
- Danish Gas Technology Centre (Denmark)
- ALK-Abelló (Denmark)
- Bioneer (Denmark)
- Danish National Metrology Institute
- Lyngsø Marine (Denmark)
- Delta (Denmark)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.